Denali Therapeutics Inc. - DNLI
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jan 08, 2026 | President and CEO | S | D | 35,198.0 | 16.5 | 580,767.0 | 296,833.0 | View | |
| Jan 08, 2026 | COFO and Secretary | S | D | 17,218.0 | 16.5 | 284,097.0 | 282,828.0 | View | |
| Jan 05, 2026 | COFO and Secretary | A | A | 173,100.0 | 0.0 | 0.0 | 173,100.0 | View | |
| Jan 05, 2026 | COFO and Secretary | A | A | 57,700.0 | 0.0 | 0.0 | 300,046.0 | View | |
| Jan 05, 2026 | President and CEO | A | A | 236,880.0 | 0.0 | 0.0 | 236,880.0 | View | |
| Jan 05, 2026 | President and CEO | A | A | 78,960.0 | 0.0 | 0.0 | 332,031.0 | View | |
| Dec 15, 2025 | — | P | A | 2,095,191.0 | 17.49 | 36,644,890.59 | 25,996,310.0 | View | |
| Dec 15, 2025 | — | P | A | 190,523.0 | 17.49 | 3,332,247.27 | 2,335,469.0 | View | |
| Nov 06, 2025 | — | A | A | 31,897.0 | 0.0 | 0.0 | 31,897.0 | View | |
| Nov 06, 2025 | — | A | A | 10,632.0 | 0.0 | 0.0 | 10,632.0 | View |